Physician profile
Waseem Farooq
NPI 1740801489
$2,442.46
in general payments reported to CMS, 2019-2025
4 companies · $2,138 in 2025
The $2,138 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $304 · 2025: $2,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,543 · Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,542.59 |
| Food and Beverage | $899.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $2,096.50 | 2025 | Carto 3 |
| Abiomed | $161.99 | 2024 | Impella |
| Edwards Lifesciences Corporation | $142.19 | 2024 | Sapien 3 Ultra Resilia |
| Angiodynamics, INC. | $41.78 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waseem Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.